• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.

出版信息

Vet Comp Oncol. 2016 Dec;14(4):417-446. doi: 10.1111/vco.283.

DOI:10.1111/vco.283
PMID:28530307
Abstract
摘要

相似文献

1
Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.兽医肿瘤协作组——犬猫化疗或生物抗肿瘤治疗后不良事件通用术语标准（VCOG-CTCAE）v1.1版
Vet Comp Oncol. 2016 Dec;14(4):417-446. doi: 10.1111/vco.283.
2
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats.兽医合作肿瘤学组-在犬猫接受试验性治疗后的不良事件通用术语标准（VCOG-CTCAE v2）。
Vet Comp Oncol. 2021 Jun;19(2):311-352. doi: 10.1111/vco.12677. Epub 2021 Feb 18.
3
[Chemotherapy discussion].[化疗讨论]
Tijdschr Diergeneeskd. 2004 Jun 1;129(11):382.
4
Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.兽医合作肿瘤学组 - 犬猫化疗或生物抗肿瘤治疗后不良事件通用术语标准（VCOG-CTCAE）v1.0
Vet Comp Oncol. 2004 Dec;2(4):195-213. doi: 10.1111/j.1476-5810.2004.0053b.x.
5
Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.外周性淋巴结淋巴瘤犬的反应评估标准（v1.0）——兽医合作肿瘤学组（VCOG）共识文件。
Vet Comp Oncol. 2010 Mar;8(1):28-37. doi: 10.1111/j.1476-5829.2009.00200.x.
6
[Chemotherapy of tumors in dogs].[犬类肿瘤的化疗]
Tijdschr Diergeneeskd. 1988 Mar 15;113(6):299-310.
7
Electrochemotherapy in Veterinary Oncology: State-of-the-Art and Perspectives.兽医肿瘤学中的电化学疗法：现状与展望
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):967-979. doi: 10.1016/j.cvsm.2019.04.006. Epub 2019 Jun 6.
8
The role of clinical trials in veterinary oncology.临床试验在兽医肿瘤学中的作用。
Vet Clin North Am Small Anim Pract. 2014 Sep;44(5):977-87. doi: 10.1016/j.cvsm.2014.05.006.
9
Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.犬实体瘤反应评估标准（第1.0版）：兽医肿瘤协作组（VCOG）共识文件
Vet Comp Oncol. 2015 Sep;13(3):176-83. doi: 10.1111/vco.12032. Epub 2013 Mar 28.
10
Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*.比较两种问卷评估接受化疗的犬猫胃肠道毒性的效果*。
Vet Comp Oncol. 2011 Sep;9(3):225-31. doi: 10.1111/j.1476-5829.2010.00259.x. Epub 2011 Jan 21.

引用本文的文献

1
Efficacy of formula against canine lymphoma chemotherapy-induced myelosuppression.配方对犬淋巴瘤化疗引起的骨髓抑制的疗效。
Front Vet Sci. 2025 Aug 12;12:1635504. doi: 10.3389/fvets.2025.1635504. eCollection 2025.
2
Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.犬源化抗CTLA-4抗体作为犬抗PD-L1难治性肿瘤挽救性联合治疗方案的研发。
Front Immunol. 2025 May 20;16:1570717. doi: 10.3389/fimmu.2025.1570717. eCollection 2025.
3
Comparative oncology in action: vignettes on immunotherapy development.
行动中的比较肿瘤学：免疫疗法发展的案例
Vet Oncol. 2025;2(1):5. doi: 10.1186/s44356-025-00017-4. Epub 2025 Feb 14.
4
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project.雷帕霉素在衰老犬类中的试验（TRIAD）：一项针对犬类衰老项目中健康中年犬的雷帕霉素前瞻性、平行组、双盲、随机、安慰剂对照、多中心试验的研究设计及原理。
Geroscience. 2025 Feb 14. doi: 10.1007/s11357-024-01484-7.
5
Palliative endoscopic debulking treatment of canine nasal carcinoma - 35 cases (2016 to 2019): A retrospective multicentric study.犬鼻腔癌的姑息性内镜减瘤治疗——35例（2016年至2019年）：一项回顾性多中心研究
Can Vet J. 2025 Feb;66(2):159-167.
6
Long-Term Survival in Canine Hepatosplenic T-Cell Lymphoma Treated with Toceranib Phosphate Following Splenectomy: A Case of Atypical Lymphoma.脾切除术后用磷酸托西拉尼治疗的犬肝脾T细胞淋巴瘤的长期存活：一例非典型淋巴瘤病例
Vet Sci. 2024 Oct 1;11(10):458. doi: 10.3390/vetsci11100458.
7
Preclinical/clinical trials of thrice-weekly administration of a combination of tegafur/gimeracil/oteracil (TS-1) and toceranib phosphate in dogs with intranasal tumors.替加氟/吉美嘧啶/奥替拉西（TS-1）联合磷酸替莫唑胺在鼻腔肿瘤犬中的临床前/临床试验。
J Vet Med Sci. 2024 Nov 1;86(11):1129-1135. doi: 10.1292/jvms.23-0455. Epub 2024 Oct 3.
8
Impact of Toceranib Phosphate and Carprofen on Survival and Quality of Life in Dogs with Inflammatory Mammary Carcinomas.磷酸托西拉尼和卡洛芬对炎性乳腺癌犬生存及生活质量的影响
Vet Sci. 2024 Sep 13;11(9):430. doi: 10.3390/vetsci11090430.
9
Immunotherapeutic allogeneic dendritic cell and autologous tumor cell fusion vaccine alone or combined with radiotherapy in canine oral malignant melanoma is safe and potentially effective.免疫治疗性同种异体树突状细胞与自体肿瘤细胞融合疫苗单独使用或联合放疗治疗犬口腔恶性黑色素瘤是安全且可能有效的。
Front Vet Sci. 2024 Aug 20;11:1397518. doi: 10.3389/fvets.2024.1397518. eCollection 2024.
10
Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma.评估磷酸替罗尼布在患有大体型乳腺腺癌的猫中的疗效和安全性。
J Feline Med Surg. 2024 Aug;26(8):1098612X241256473. doi: 10.1177/1098612X241256473.